Literature DB >> 11377567

Basiliximab in the therapy of acute rejection after organ transplantation.

M N Chariat1, M Erren, M Chariat, M Deng, H H Wolters, K H Dietl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11377567     DOI： 10.1016/s0041-1345(01)02029-2

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  2 in total

1.  Basiliximab for the therapy of acute T cell-mediated rejection in kidney transplant recipient with BK virus infection: A case report.

Authors:  Tingting Chen; Xiaoyu Li; Jina Wang; Xuanchuan Wang; Tongyu Zhu; Ruiming Rong; Cheng Yang
Journal:  Front Immunol       Date:  2022-09-23       Impact factor: 8.786

2.  The role of basiliximab in the evolving renal transplantation immunosuppression protocol.

Authors:  Paola Salis; Chiara Caccamo; Roberto Verzaro; Salvatore Gruttadauria; Mary Artero
Journal:  Biologics       Date:  2008-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.